CHJ.23758
Lysostaphin from Staphylococcus staphylolyticus
--
--
Ordering
Available Variants2 mg
CHJ.23758-2mg
Price
€168.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
2 mg | CHJ.23758-2mg | €168.00 |
free of DNA contaminants, ≥500 units/mg protein, lyophilized powder, suitable for Microbiome research
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 9011-93-2 |
|---|---|
| UNSPSC Code | 12352202 |
| NACRES | NA.54 |
| EC Number | 3.4.24.75 (BRENDA, IUBMB) |
| MDL number | MFCD00131556 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H334 |
| pcodes | P261 - P284 - P501 |
| Hazard Classifications | Resp. Sens. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Lysostaphin, a glycylglycine endopeptidase, is an enzyme derived from Staphylococcus staphylolyticus with a CAS number of 9011-93-2. This bacteriolytic enzyme specifically targets and cleaves the pentaglycine crosslinks in the peptidoglycan layer of Staphylococcus cell walls, ultimately leading to cell lysis. The unique specificity of lysostaphin makes it an effective agent against Staphylococcus species, including methicillin-resistant Staphylococcus aureus. As a potential therapeutic agent, lysostaphin has been explored for its use in treating Staphylococcus-related infections, particularly in cases where traditional antibiotics are ineffective. Further research is necessary to fully understand the potential applications and limitations of lysostaphin as a treatment option for bacterial infections. The enzymes mechanism of action and specificity make it an interesting subject for ongoing scientific investigation and potential clinical development.
